MOST people pray they won’t be struck with cancer even once in a lifetime – let alone 170 times. But that’s the reality for Sean Breininger, who is nothing short of a miracle, having ...

Improved radiographic progression-free survival (rPFS) regardless of disease volume or metastatic presentation achieved with ...

Inside the labs and clinics where founders, physicians, and researchers are betting their lives on 'solving' ageing.

In the race to forge the next Keytruda from PD-(L)1xVEGF bispecific antibodies, Pfizer and the BioNTech-Bristol Myers Squibb alliance are split on how to position overall survival—the gold-standard ...

Fred Hutch Cancer Center has increased financial and administrative support for oncology nurses eager to flex their research muscles by publishing articles in peer-reviewed journals and presenting at ...

Christy Redican grew up in Connecticut, spending summers sailing and playing tennis. “I was a sun worshipper,” she said. “I did all the things you’re not supposed to do. I have fair skin, blonde hair ...

Regulated cell death (RCD) comprises a diverse and expanding set of molecularly defined processes, such as apoptosis, necroptosis, ferroptosis, and ...

Researchers have demonstrated a promising new approach to stopping pancreatic cancer before it starts, using experimental drugs to eliminate microscopic precancerous lesions in the pancreas.

ExThera claimed its blood filters could treat cancer but several patients say the procedure worsened their conditions and even contributed to deaths.

The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.

A cancer-killing virus has stopped pancreatic tumours from growing and spreading in three people in an initial safety trial, ...

Revolution Medicines’ success in pancreatic cancer has ignited interest in a new type of medicine that’s sending dealmaking into overdrive.